A detailed history of Marathon Capital Management transactions in Stryker Corp stock. As of the latest transaction made, Marathon Capital Management holds 953 shares of SYK stock, worth $343,337. This represents 0.09% of its overall portfolio holdings.

Number of Shares
953
Previous 953 -0.0%
Holding current value
$343,337
Previous $341,000 4.99%
% of portfolio
0.09%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$266.54 - $302.43 $2,132 - $2,419
8 Added 0.85%
953 $260,000
Q1 2023

May 12, 2023

BUY
$246.13 - $285.47 $232,592 - $269,769
945 New
945 $269,000
Q1 2022

May 13, 2022

SELL
$245.33 - $277.77 $231,836 - $262,492
-945 Closed
0 $0
Q4 2021

Feb 09, 2022

SELL
$236.63 - $276.44 $106,010 - $123,845
-448 Reduced 32.16%
945 $253,000
Q3 2021

Nov 15, 2021

BUY
$248.9 - $280.09 $111,507 - $125,480
448 Added 47.41%
1,393 $368,000
Q4 2020

Feb 08, 2021

BUY
$202.01 - $245.04 $190,899 - $231,562
945 New
945 $231,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $136B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Marathon Capital Management Portfolio

Follow Marathon Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Capital Management with notifications on news.